Final analysis from RESONATE: Six-year follow-up in patients (pts) with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) on ibrutinib. Barr, P. M., Munir, T., Brown, J. R., O'Brien, S., Barrientos, J., Reddy, N. M., Coutre, S., Tam, C., Mulligan, S. P., Jager, U., Kipps, T. J., Moreno, C., Montillo, M., Burger, J., Byrd, J. C., Hillmen, P., Dai, S., Szoke, A., Dean, J. P., Woyach, J. AMER SOC CLINICAL ONCOLOGY. 2019

View details for Web of Science ID 000487345806272